NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/18/2024
Back to search
Official data from USPTO
VASCUGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
06/18/2024
Trademark type
Word
Nice classes
42
Filing date
11/10/2020
Registration date
06/18/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/18/2024
Last transaction
06/18/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2022-06-00
First use in commerce
2022-06-00
Drawing code
4
Owner type
03
Owner location
Madison, WI, US
Examiner
JOHN, CRISTEL M
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Vascugen, Inc.
Representatives
Katherine P. Califa FOLEY & LARDNER LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Development of pharmaceutical preparations and medicines; medical and scientific research in the field of vascular and cardiovascular impairments; medical and scientific research in the field of allogeneic cell therapy; medical and scientific research in the field of regenerative medicine; providing medical and scientific research information in the field of regenerative medicinevascular and cardiovascular impairmentsallogenic cell therapies; medical and scientific research in the field of treatment and prevention of critical limb ischemiadiabetic foot ulcerperipheral artery diseasediabetic retinopathyage-related macular degenerationheart failurestroketraumatic brain injuryacute kidney injuryacute respiratory distress syndromebronchopulmonary dysplasia
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/18/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/13/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/13/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/10/2024
IUAF
USE AMENDMENT FILED
05/08/2024
EISU
TEAS STATEMENT OF USE RECEIVED
05/08/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/12/2023
EX5G
SOU EXTENSION 5 GRANTED
12/11/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/11/2023
EXT5
SOU EXTENSION 5 FILED
12/01/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/01/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/15/2023
EX4G
SOU EXTENSION 4 GRANTED
07/13/2023
EXT4
SOU EXTENSION 4 FILED
07/13/2023
EEXT
SOU TEAS EXTENSION RECEIVED
07/13/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/24/2023
EX3G
SOU EXTENSION 3 GRANTED
01/20/2023
EXT3
SOU EXTENSION 3 FILED
01/20/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/20/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/28/2022
EX2G
SOU EXTENSION 2 GRANTED
06/24/2022
EXT2
SOU EXTENSION 2 FILED
06/24/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/24/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/05/2022
EX1G
SOU EXTENSION 1 GRANTED
01/03/2022
EXT1
SOU EXTENSION 1 FILED
01/03/2022
EEXT
SOU TEAS EXTENSION RECEIVED
01/03/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/27/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/01/2021
PUBO
PUBLISHED FOR OPPOSITION
06/01/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/12/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/29/2021
DOCK
ASSIGNED TO EXAMINER
04/19/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/09/2021
NWAP
NEW APPLICATION ENTERED
11/13/2020
Continuous trademark protection
Get notified about every new filing that threatens VASCUGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.